GIMV

Private Equity Antwerpen, Vlaanderen, Belgium ·Founded 1980

Overview

No.1 Belgium based investor. Growth equity focus.

Investment Focus

  • Companies with high-growth potential
  • Entrepreneurial and innovative management teams
  • Alignment with one of Gimv's investment platforms

Portfolio Companies

BiotalysCeresCovagenDigital InsightOnwardSanthera PharmaceuticalsAclara TechnologiesAnjarium BiosciencesImmunOs Therapeutics

Reach GIMV directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about GIMV

What sectors does GIMV invest in?

GIMV invests in Real Estate, Consumer, FinTech, Transportation, Life Sciences and Medtech, and is based in Antwerpen, Vlaanderen, Belgium. GIMV is listed as a private equity in the ConnectSafely investor database.

What stage does GIMV invest at?

GIMV backs companies at Seed, Series A, Series B, Growth, Buyout and Turnaround, writing cheques of 5M - 75M.

Which regions does GIMV invest in?

GIMV invests across United States, United Kingdom, Germany, France, Italy and Denmark.

Who are the partners at GIMV?

Team members listed for GIMV include Edmond Bastijns (Chief Legal Officer - Secretary General) and Koen Dejonckheere (CEO).

What companies has GIMV invested in?

GIMV's portfolio includes Biotalys, Ceres, Covagen, Digital Insight, Onward, Santhera Pharmaceuticals, Aclara Technologies and Anjarium Biosciences.

How do I contact GIMV?

GIMV's contact details — including work email, phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database